Plasma endothelin-1, homocysteine and serum nitric oxide values in patients with left-to-right shunt

Indian Heart Journal

Volumn 56, Issue 6, 2004, Pages 653-657

  Ozerol, Ibrahim H ^a   Pac, Feyzanur A ^a   Ozerol, Elif ^a   Ege, Erdal ^a   Yologlu, Saim ^a   Temel, Ismail ^a   Pac, Mustafa ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Congenital heart disease; Left to right shunt; Nitric oxide

Indexed keywords

ENDOTHELIN 1; HOMOCYSTEINE; NITRATE; NITRIC OXIDE; NITRITE;

ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LEFT RIGHT SHUNT; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG ARTERY PRESSURE; LUNG BLOOD FLOW; MAJOR CLINICAL STUDY; PULMONARY HYPERTENSION; VASCULAR ENDOTHELIUM;

BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; ENDOTHELIN-1; FEMALE; HEART DEFECTS, CONGENITAL; HOMOCYSTEINE; HUMANS; HYPERTENSION, PULMONARY; MALE; NITRIC OXIDE;

EID: 14144249456     PISSN: 00194832     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 1998; 114: 208S-212S
2. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142
3. Yanagisawa M. The endothelin system. A new target for therapeutic intervention. Circulation 1994; 89: 1320-1322
4. Michael JR, Markewitz BA. Endothelins and the lung. Am J Respir Crit Care Med 1996; 154: 555-581
5. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989; 86: 3375-3378
6. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000
7. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48: 489-509
8. Takaya J, Ikemoto Y, Teraguchi M, Nogi S, Kobayashi Y. Plasma nitric oxide products correlate with cardiac index of congenital heart disease. Pediatr Cardiol 2000; 21: 378-381
9. Langman LJ, Cole DE Homocysteine. Crit Rev Clin Lab Sci 1999; 36: 365-406
10. Okatani Y, Wakatsuki A, Reiter RJ. Protective effect of melatonin against homocysteine-induced vasoconstriction of human umbilical artery. Biochem Biophys Res Commun 2000; 277: 470-475
11. Cooke JP, Stamler J, Andon N, Davies PF, McKinley G, Loscalzo J. Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol 1990; 259: H804-H812
12. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986; 8: 37-44
13. Young MA, Vatner SF. Blood flow- and endothelium-mediated vasomotion of iliac arteries in conscious dogs. Circ Res 1987; 61: 1188-1193
14. Janakidevi K, Fisher MA, Del Vecchio PJ, Tiruppathi C, Figge J, Malik AB. Endothelin-1 stimulates DNA synthesis and proliferation of pulmonary artery smooth muscle cells. Am J Physiol 1992; 263: C1295-C1301
15. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249-252
16. 2+ channels. J Hypertens 1988; 6(Suppl): S188-S191
17. Ryan US, Glassberg MK, Nolop KB. Endothelin-1 from pulmonary artery and microvessels acts on vascular and airway smooth muscle. J Cardiovasc Pharmacol 1989; 13: S57-S62
18. Lippton HL, Hauth TA, Summer WR, Hyman AL. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Physiol 1989; 66: 1008-1012
19. Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989; 161: 1220-1227
20. Pernow J, Hemsen A, Lundberg JM. Increased plasma levels of endothelin-like immunoreactivity during endotoxin administration in the pig. Acta Physiol Scand 1989; 137: 317-318
21. Cacoub P, Dorent R, Maistre G, Nataf P, Carayon A, Piette Q et al. Endothelin-1 in primary pulmonary hypertension and the Eisenmenger syndrome. Am J Cardiol 1993; 71: 448-450
22. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 1993; 123: 109-114
23. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med 1991; 114: 464-469
24. Yamamoto K, Ikeda U, Mito H, Fujikawa H, Sekiguchi H, Shimada K. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 1994; 89: 2093-2098
25. Yoshibayashi M, Nishioka K, Nakao K, Saito Y, Matsumura M, Ueda T, et al. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 1991; 84: 2280-2285
26. Ishikawa S, Miyauchi T, Sakai S, Ushinohama H, Sagawa K, Fusazaki N, et al. Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. J Thorac Cardiovasc Surg 1995; 110: 271-273
27. Adatia I, Haworth SG. Circulating endothelin in children with congenital heart disease. Br Heart J 1993; 69: 233-236.
28. Gorenflo M, Gross P, Bodey A, Schmitz L, Brockmeier K, Berger F, et al. Plasma endothelin-1 in patients with left-to-right shunt. Am Heart J 1995; 130: 537-542
29. Dupuis J, Cernacek P, Tardif JC, Stewart DJ, Gosselin G, Dyrda I, et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J 1998; 135: 614-620
30. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995; 333: 214-221
31. Miyauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 1993; 73: 887-897
32. Wong J, Reddy VM, Hendricks-Munoz K, Liddicoat JR, Gerrets R, Fineman JR. Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow. Am J Physiol 1995; 269: H1965-H1972
33. Fanapour PC, Yug B, Kochar MS. Hyperhomocysteinemia: an additional cardiovascular risk factor. WMJ 1999; 98: 51-54
34. De Laet C, Wautrecht JC, Brasseur D, Dramaix M, Boeynaems JM, Decuyper J, et al. Plasma homocysteine concentration in a Belgian school-age population. Am J Clin Nutr 1999; 69: 968-972
35. Wang S, Wright G, Harrah J, Touchon R, McCumbee W, Geng W, et al. Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism. Can J Physiol Pharmacol 2000; 78: 500-506
36. Pruefer D, Scalia R, Lefer AM. Homocysteine provokes leukocyte- endothelium interaction by downregulation of nitric oxide. Gen Pharmacol 1999; 33: 487-498